Çѱ¹¹ÙÀÌ¿ÀÀǾàÇ°Çùȸ¿¡¼ ¾È³»µå¸³´Ï´Ù.
½ÄÇ°ÀǾàÇ°¾ÈÀüó´Â ¼¼°èº¸°Ç±â±¸(WHO) ¹ÙÀÌ¿ÀÀǾàÇ° Ç¥ÁØÈ ºÐ¾ß Çù·Â¼¾Åͷμ ±¹Á¦ ±âÁØ Á¦,°³Á¤¿¡ °øµ¿À¸·Î Âü¿©ÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ¿Í °ü·ÃÇÏ¿© WHO¿¡¼ ¾Æ·¡¿Í °°ÀÌ ÀÎÇ÷翣ÀÚ¹é½Å, EÇü °£¿°¹é½Å ¹× ¹ÙÀÌ¿À½Ã¹Ð·¯ÀÇ °¡À̵å¶óÀÎ(¾È)¿¡ ´ëÇÑ °ËÅäÀÇ°ßÀ» ¼ö·ÅÇÏ°í ÀÖ½À´Ï´Ù.
- ¾Æ ·¡ -
°¡. ÀÎÇ÷翣ÀÚ ¹é½Å Èĺ¸ ¹ÙÀÌ·¯½ºÀÇ Ç°Áú°ü¸®¿¡ °üÇÑ »ý¹°¾ÈÀü À§ÇèÆò°¡ ¹× °¡À̵å¶óÀÎ
³ª. ÀçÁ¶ÇÕ EÇü °£¿° ¹é½ÅÀÇ Ç°Áú, ¾ÈÁ¤¼º ¹× È¿´É È®ÀÎÀ» À§ÇÑ ±ÇÀå»çÇ×
´Ù. WHO ÁúÀÇ ¹× ÀÀ´äÁý: ¹ÙÀÌ¿À½Ã¹Ð·¯ Á¦Ç°
°¢ °¡À̵å¶óÀÎ °¡~´Ù¿¡ ´ëÇÑ °ËÅäÀÇ°ßÀÌ ÀÖ´Â °æ¿ì, 2018.1.18.(¸ñ)±îÁö °¢ ÷ºÎµÈ ÀÇ°ß¾ç½Ä¼¸¦ ÀÛ¼ºÇÏ¿© ¿ì¸® Çùȸ(johs8739@kobia.kr)·Î Á¦ÃâÇÏ¿© Áֽñ⠹ٶø´Ï´Ù.
°¨»çÇÕ´Ï´Ù.
[÷ºÎÆÄÀÏ]
ºÙÀÓ1. WHO biosafety risk assessment and guidelines for the production and quality control of novel human influenza candidate vaccine viruses
ºÙÀÓ1. PANDEMIC_FLU_BIOSAFETY_Comment_Form_1st_PC_112017(°ËÅäÀÇ°ß¼)
ºÙÀÓ2. Recommendations to assure the quality safety and efficacy of recombinant hepatitis E vaccines
ºÙÀÓ2. HEP_E_Comment_Form(°ËÅäÀÇ°ß¼)
ºÙÀÓ3. WHO Questions and Answers_Similar Biotherapeutic Products
ºÙÀÓ3. WHO_QA_Comment_Form_WHO_QA_30_Nov_2017(°ËÅäÀÇ°ß¼). ³¡